Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts

Circulation Research

Volumn 83, Issue 12, 1998, Pages 1205-1214

  Baker, Debra L ^a   Hashimoto, Katsuji ^b   Grupp, Ingrid L ^a   Ji, Yong ^a   Reed, Thomas ^a   Loukianov, Evgenij ^a   Grupp, Gunter ^a   Bhagwhat, Ajit ^a   Hoit, Brian ^a   Walsh, Richard ^a   Marban, Eduardo ^b   Periasamy, Muthu ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Ca2+ uptake; Sarcoplasmic reticulum Ca2+ ATPase; Transgenic mice; Working heart model

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM);

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; ENZYME LOCALIZATION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE;

EID: 0032576586     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.12.1205     Document Type: Article

References (55)

1. Lytton J, MacLennan DH. Sarcoplasmic reticulum. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. 2nd ed. New York: Raven Press; 1992: 1203-1222.
2. 2+ dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature. 1985;316:696-700.
3. 2+ ATPase genes. Homologies and mechanistic implications of deduced amino acid sequences. Cell. 1986;44:597-607.
4. 2+ ATPase of the sarcoplasmic reticulum: expression in developing skeletal muscle. J Biol Chem. 1987;262:3768-3774.
5. 2+ ATPase gene. J Biol Chem. 1990;265:4670-4677.
6. 2+ ATPase gene. J Biol Chem. 1988;263:15032-15040.
7. 2+ ATPase. J Biol Chem. 1989;264:7059-7065.
8. 2+ pump. J Biol Chem. 1989;264:18561-18568.
9. 2+ ATPase isoforms transcripts. Am J Physiol. 1995;269:C775-C784.
10. Arai M, Otsu K, MacLennan DH, Periasamy M. Regulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development. Am J Physiol. 1992;262:C614-C620.
11. 2+ ATPase isoforms during ontogeny in the rat. J Mol Cell Cardiol. 1994;26: 539-550.
12. 2+ pumps and their modulation by phospholamban. Biochem J. 1992;286:591-596.
13. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 1994;74:555-564.
14. 2+ ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci U S A. 1989;86:2966-2970.
15. Arai M, Otsu K, MacLennan DH, Alpert NR, Periasamy M. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ Res. 1991;69:266-276.
16. Suko J. The calcium pump of the cardiac sarcoplasmic reticulum: functional alterations at different levels of thyroid state in rabbits. J Physiol (Lond). 1983;228:563-582.
17. 2+ ATPase and myosin heavy chain α gene expression in cardiac myocytes. J Biol Chem. 1991; 266:8638-8646.
18. 2+-cycling proteins in the baboon. Circ Res. 1996;79:727-735.
19. Hoit BD, Pawloski-Dahm CM, Shao Y, Gabel M, Walsh RA. The effects of a thyroid hormone analog on left ventricular performance and contractile and calcium cycling proteins in the baboon. Proc Am Assoc Physicians. 1997;109:146-153.
20. Matsui H, MacLennan DH, Alpert NR, Periasamy M. Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. Am J Physiol. 1995;268:C252-C258.
21. 2+ ATPase gene in pressure overload induced cardiac hypertrophy in the rat. Circ Res. 1990;66:554-564.
22. 2+-ATPase protein levels. Circ Res. 1995;77:759-764.
23. Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation. 1990;81(suppl III):III-21-III-32.
24. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70-76.
25. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-469.
26. 2+ ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 1990;85:305-309.
27. 2+ ATPase gene. Circ Res. 1992;71:9-17.
28. 2+ exchanger in end-stage human heart failure. Circ Res. 1994;443-453.
29. 2+-ATPase in failing and nonfailing human myocardium. Circ Res. 1994;75:434-442.
30. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol. 1997;92:87-93.
31. Hajjar RJ, Kang JX, Gwathmey JK, Rosenzweig A. Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation. 1997;95:423-429.
32. Inesi G, Lewis D, Sumbilla C, Nandi A, Strock C, Huff KW, Rogers TB, Johns DC, Kessler PD, Ordahl CP. Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytes. Am J Physiol. 1998;274:C645-C653.
33. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest. 1997;100:380-389.
34. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. Tissue-specific regulation of the alpha myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991;266:24613-24620.
35. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem. 1991;266:9180-9185.
36. Hogan B, Constantini F, Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1986:79-173.
37. Walter CA, Nasr-Schirf D, Luna VJ. Identification of transgenic mice carrying the CAT gene with PCR amplification. Biotechniques. 1989;7: 1065-1070.
38. Sambrook J, Fritsch EF, Mantiatis T. Analysis of genomic DNA by Southern hybridization. In: Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989;9.31-9.62.
39. Carson FL. Histotechnology: A Self-Instructional Text. Chicago: ASCP Press; 1990:25-37, 103-105.
40. Brown T. Analysis of RNA by Northern and slot blot hybridization. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology. New York: John Wiley & Sons, Inc; 1994:4.9.1-4.9.14.
41. Harrer JM, Kiss E, Kranias EG. Applications of the immunoblot technique for quantitation of protein levels in cardiac homogenates. Biotechniques. 1995;18:995-997.
42. 2+-pump isoforms and of phospholamban in pig smooth-muscle tissues. Biochem J. 1990;271:649-653.
43. Ganim JR, Luo W, Ponniah S, Grupp I, Kim HW, Ferguson DG, Kadambi V, Neumann JC, Doetschman T, Kranias EG. Mouse phospholamban gene expression during development in vivo and in vitro. Circ Res. 1992;71:1021-1030.
44. 2+ by sarcoplasmic reticulum fragments. J Biol Chem. 1964;239:648-658.
45. 2+ ion concentration by metal chelators. In: Schwartz A, ed. Methods in Pharmacology. New York: Plenum Publishing Corp; 1984:63-75.
46. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol. 1993;265: H1401-H1410.
47. Gao WD, Perez NG, Marban E. Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol (Lond). 1998;507: 175-184.
48. 2+ sensitivity in intact versus skinned rat ventricular muscle. Circ Res. 1994;74:408-415.
49. 2+] in intact rat cardiac trabeculae. J Gen Physiol. 1995;105:1-19.
50. 2+ ATPase. Circ Res. 1997;81:145-153.
51. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res. 1994;75:401-409.
52. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW 2nd, Walsh RA, Kranias EG. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest. 1996;97:533-539.
53. Cornea RL, Jones LR, Autry JM, Thomas DD. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry. 1997;36:2960-2967.
54. Chu G, Dorn GW 2nd, Luo W, Harrer JM, Kadambi VJ, Walsh RA, Kranias EG. Monomeric phospholamban overexpression in transgenic mouse hearts. Circ Res. 1997;81:485-492.
55. 2+-ATPase. Circ Res. 1998;83:889-897.